N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells is a research paper published in Frontiers in Endocrinology (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01 DK119359, R01 DK052194
National Heart, Lung, and Blood Institute
Grant: T32 HL134643
National Institute of Allergy and Infectious Diseases
Grant: R01 AI044458
National Institutes of Health
Grant: 5R01DK052194-08
Biochemical mechanism of beta-cell destruction
National Institutes of Health
Grant: 5R01DK119359-04
Biochemical mechanisms of beta cell protection through bromodomain inhibition
National Institutes of Health
Grant: 1T32HL134643-01
Training in Signature Transdisciplinary Cardiovascular Sciences
National Institutes of Health
Grant: 5R01AI044458-03
MECHANISMS OF VIRAL INDUCED BETA CELL DAMAGE
Fields of Study
Keywords